Communication and collaboration yields a reduction in behaviors
By
Janean Kinzie
Oct 25, 2021
Reducing antipsychotic medication use in long-term care residents has been a focus for both nursing home operators and practitioners for nearly 10 years since the launch of the Center for Medicare & Medicaid...
Promising Alzheimer’s drug fails in follow-up tests, researchers announce
By
McKnight's Staff
May 28, 2013
A “breakthrough” Alzheimer’s drug now looks much less promising after follow-up experiments failed to reproduce successful results, scientists recently announced. Non-standard use of...
Judge dismisses claims of ‘nationwide’ Medicare fraud in Omnicare antipsychotics case
By
McKnight's Staff
May 23, 2013
Long-term care pharmacy Omnicare will not face charges that it engaged in “nationwide” Medicare fraud for off-label antipsychotics prescriptions, a federal judge recently ruled. However, the...
Proposed legislation would regulate use of antipsychotics in nursing home residents
By
McKnight's Staff
May 23, 2012
A proposed bill would require nursing home staff to obtain informed consent from a resident or their legally designated representative acknowledging the potential risks and side effects associated with...
Antipsychotic likely to increase mortality risk in dementia residents, study finds
By
McKnight's Staff
Feb 28, 2012
Nursing home residents being treated for dementia with the antipsychotic drug haloperidol were at a two-fold risk of mortality compared to other antipsychotics, a new study finds.
